share_log

白云山(600332.SH):子公司收到澳门药品注册证书

BAIYUNSHAN PH (600332.SH): Subsidiary received the pharmaceutical registration certificate from Macau.

Gelonghui Finance ·  Jan 9 19:03

On January 9, Gelonghui announced that BAIYUNSHAN PH (600332.SH) reported that its holding subsidiary, Guangzhou BAIYUNSHAN Guanghua Pharmaceutical Co., Ltd., received the "Chinese Patent Medicine Registration Certificate" issued by the Macao Special Administrative Region's Drug Administration, with the product names: Xiao Chai Hu Granules (sugar-free type) [BAIYUNSHAN], Xiao Chai Hu Granules [BAIYUNSHAN]. The functions and indications of Xiao Chai Hu Granules are to release the exterior, disperse heat, and soothe the liver and stomach. It is used for external contraction diseases, with pathogenic factors invading the Shaoyang syndrome, symptoms include alternating chills and fever, fullness in the chest and hypochondria, loss of appetite, irritability with a tendency to vomit, and bitter taste in the mouth with dryness in the throat.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment